OncoMed Pharma (OMED) Misses Q1 EPS by 17c
Tweet
Share
E-mailGet Alerts OMED Hot Sheet
Join SI Premium – FREE
OncoMed Pharma (NASDAQ: OMED) reported Q1 EPS of ($0.90), $0.17 worse than the analyst estimate of ($0.73). Revenue for the quarter came in at $6.4 million versus the consensus estimate of $8.28 million.
For earnings history and earnings-related data on OncoMed Pharma (OMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Grainger (GWW) Tops Q1 EPS by 2c, provides guidance
- Morphic Holding, Inc. (MORF) Tops Q1 EPS by 6c
- Tractor Supply (TSCO) Tops Q1 EPS by 12c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
